Sponsor or institution

Clinical trials and research at Avistone Biotechnology Co., Ltd.

• 7Clinical trials
• 3Countries

Newest trials

All recruiting trials (7)

• ANS02 in EGFR-mutant NSCLC (early-phase study)

  This first-in-human study tests ANS02 in adults with advanced EGFR-mutant non-small cell lung cancer to see if it is safe, tolerable, and shows any tumor activity.

  Recruiting at 2 sites Phase 1/2 Avistone Biotechnology Co., Ltd. · Fairfax, Virginia and 4 other locations · NCT07538804

• Andamertinib, alone or with platinum-doublet chemotherapy, versus platinum-doublet chemotherapy for non-squamous NSCLC with atypical EGFR mutations

  This trial tests whether the targeted pill andamertinib, given alone or with platinum-doublet chemotherapy, helps people with untreated advanced non-squamous NSCLC that has atypical EGFR mutations respond better or live longer than standard platinum-doublet chemotherapy.

  Recruiting Phase 2 Avistone Biotechnology Co., Ltd. · Guangzhou · NCT07336732

• Investigating ANS03 for advanced solid tumors with specific genetic alterations

  This study is testing a new treatment called ANS03 to see if it can help people with advanced solid tumors that have specific genetic changes.

  Recruiting at 5 sites Phase 1 Avistone Biotechnology Co., Ltd. · New York, New York and 4 other locations · NCT06716138

• First-line treatment for advanced lung cancer with specific genetic mutations

  This study is testing a new combination treatment for people with advanced lung cancer that has specific genetic mutations to see if it helps them feel better and live longer.

  Recruiting Phase 2 Avistone Biotechnology Co., Ltd. · Guangzhou, Guangdong · NCT06574347

• Combining Vebreltinib and PLB1004 for advanced lung cancer with specific mutations

  This study is testing a new combination of two drugs, Vebreltinib and PLB1004, to see if they can help people with advanced lung cancer who have certain genetic changes and haven't responded to previous treatments.

  Recruiting Phase 1/2 Avistone Biotechnology Co., Ltd. · Shanghai, Shanghai Municipality · NCT06343064

• Investigating ANS014004 for advanced solid tumors

  This study is testing a new drug called ANS014004 to see if it is safe and effective for adults with advanced solid tumors.

  Recruiting at 10 sites Phase 1 Avistone Biotechnology Co., Ltd. · San Diego, California and 14 other locations · NCT06307795

• Testing PLB1004 for Non-Small Cell Lung Cancer

  This study is testing a new oral medication for people with non-small cell lung cancer to see how safe it is and how well it works for those with certain genetic changes.

  Recruiting at 7 sites Phase 1 Avistone Biotechnology Co., Ltd. · Sacramento, California and 6 other locations · NCT06046495

Quick answers

How many clinical trials run by Avistone Biotechnology Co., Ltd. are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (6 trials), United States (4 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 1/2: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →